High-purity large-scale preparation of stannsoporfin

Details for Australian Patent Application No. 2007307111 (hide)

Owner InfaCare Pharmaceutical Corporation

Inventors Boucher, Christopher P.; Drummond, George S.; Caroselli, Robert; Levin, Daniel; Roe, David G.; Cooke, Keith A.

Agent Spruson & Ferguson

Pub. Number AU-B-2007307111

PCT Pub. Number WO2008/045377

Priority 60/904,601 28.02.07 US; 60/849,641 04.10.06 US

Filing date 4 October 2007

Wipo publication date 17 April 2008

Acceptance publication date 8 March 2012

International Classifications

C07D 498/22 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/555 (2006.01) - containing heavy metals, e.g. hemin, hematin, melarsoprol

C07F 7/00 (2006.01) Compounds containing elements of the 4th Group of the Periodic System

C07F 7/22 (2006.01) Compounds containing elements of the 4th Group of the Periodic System

Event Publications

7 May 2009 PCT application entered the National Phase

  PCT publication WO2008/045377 Priority application(s): WO2008/045377

8 March 2012 Application Accepted

  Published as AU-B-2007307111

5 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007307112-Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin

2007307107-Stable antibody formulations